Brief: Elanco Announces FDA Approval And Launch Of Zenrelia (Ilunocitinib Tablets)
Sept 19 (Reuters) - Elanco Animal Health Inc ELAN.N :
* ELANCO ANNOUNCES FDA APPROVAL AND LAUNCH OF ZENRELIA™
(ILUNOCITINIB TABLETS), OFFERING AN EFFECTIVE, SAFE SOLUTION IN
CANINE DERMATOLOGY
* ELANCO ANIMAL HEALTH INC: ZENRELIA LAUNCH BEGINS IN U.S.
WITH
ELANCO NOW TAKING ORDERS; PRODUCT EXPECTED TO SHIP IN COMING
DAYS
Source text for Eikon: ID:nPn9ydtnJa
Further company coverage: ELAN.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Elanco Animal Health Incorporated
See all newsBrief: Elanco Animal Health Appoints Jamie Preston As Chief People Officer
U.S. STOCKS ON THE MOVE-Walt Disney, Alphabet, Kraft Heinz
U.S. STOCKS ON THE MOVE-Wynn Resorts, Griffon, Kratos Defense, Amgen
Elanco Animal Health Incorporated reports results for the quarter ended June 30 - Earnings Summary
U.S. STOCKS ON THE MOVE-Cencora, Charles River, Twist Bioscience